Allergy Diagnostics Market - By Type: In-vitro Allergy Testing, In-vivo Allergy Testing. By Test Type: Blood Tests, Skin Tests, Patch Tests. By Allergy Type: Food Allergies, Respiratory Allergies, Drug Allergies, Insect Sting Allergies. By End-user: Hospitals, Diagnostic Laboratories, Home Care, Others. By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
The global allergy diagnostics market is undergoing a significant transformation, driven by the increasing prevalence of allergic disorders and advancements in diagnostic technologies. In 2024, the market is valued at 6.1 billion, with projections indicating it will reach 11.2 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.9%. This growth trajectory is supported by several key factors, including the rising incidence of food and respiratory allergies, the development of innovative diagnostic tools such as molecular testing and AI-powered platforms, and heightened healthcare spending in emerging economies.
ClearView Market Insights' comprehensive 250-page report offers an in-depth analysis of this dynamic market. The study provides a detailed examination of market size trends from 2021 through 2031, along with a thorough segmentation analysis by product type, allergen category, and end-user. Additionally, the report features a competitive landscape assessment, profiling major industry players and emerging disruptors shaping allergy diagnostics' future.
2. Market Overview and Key Findings
The allergy diagnostics sector has demonstrated consistent growth in recent years, with the market expanding from 4.5 billion in 2021 to 5.7 billion in 2023. This upward trend continues in 2024, with the market reaching USD6.1 billion, representing a 7.0% year-over-year increase. Looking ahead, the market is expected to maintain strong growth momentum, achieving an 8.9% CAGR through 2031.
Several notable trends are driving this expansion. Molecular allergy diagnostics has emerged as the fastest-growing segment, projected to grow at an impressive 14.2% CAGR. This growth is attributed to the technology's ability to provide more precise and comprehensive allergy profiles than traditional testing methods. Another significant development is the rising popularity of at-home testing kits, with companies like Everlywell and LetsGetChecked making allergy testing more accessible to consumers. Geographically, North America continues to dominate the market, accounting for 45% of global revenue, largely due to high healthcare expenditure and widespread adoption of advanced diagnostic technologies.
3. Market Segmentation Analysis
The allergy diagnostics market can be segmented by product type, allergen category, and end-user. Currently, immunoassay analyzers lead the product segment, generating USD 2.3 billion in revenue and capturing USD 382.3 billion in revenue (20% share), while ELISA tests and molecular diagnostics account for USD 1.0 billion and USD 161.0 billion (13%), respectively.
When examining allergen types, food allergens such as peanuts, milk, and shellfish constitute the largest category, making up 32% of the market. Inhalant allergens, including pollen and dust mites, account for 28% of the market. Regarding end-users, hospitals and clinics are the primary consumers of allergy diagnostics, representing 55% of the market, followed by diagnostic laboratories at 30%.
4. Competitive Landscape and Industry Innovations
The allergy diagnostics market features a combination of established corporations and innovative startups. Thermo Fisher Scientific retains its market leadership with a 25% share, primarily due to its ImmunoCAP system, which remains the gold standard in allergy testing. Siemens Healthineers follows with an 18% market share, while Danaher Corporation holds 12% through its Beckman Coulter diagnostics division.
Emerging companies are introducing disruptive technologies that are reshaping the industry. AllerScan is pioneering AI-driven allergy testing solutions that provide faster and more accurate results. Meanwhile, Clarityn's SmartTrack represents an innovative method for allergy monitoring utilizing wearable technology. These advancements are creating new opportunities for growth and competition within the sector.
5. Strategic Recommendations and Report Value
ClearView Market Insights' report provides stakeholders with vital data and analysis to navigate the evolving allergy diagnostics landscape. The study includes exclusive survey data collected from over 3,000 allergists worldwide, offering unique insights into testing preferences and technology adoption trends. Regulatory analysis covers the latest FDA and EMA approval patterns for novel diagnostics, assisting companies in anticipating and adapting to changing compliance requirements.
Need help?
Chat with our team in a minute.